The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenue | 795,229 | 751,213 | 754,577 | 855,170 |
| Compensation-related expense | 461,832 | 423,941 | 417,217 | 453,414 |
| General and administrative expense | 101,365 | 104,970 | 101,827 | 93,350 |
| Other segment items | 40,740 | 41,245 | 38,979 | 45,557 |
| Depreciation and amortization | 69,402 | 73,540 | 73,795 | 72,556 |
| Change in contingent consideration | 27,294 | 15,955 | 11,968 | -759 |
| Interest income | 1,146 | 1,315 | 1,749 | 4,585 |
| Interest expense | 54,879 | 54,513 | 58,093 | 117,427 |
| Income from equity method investments | 5,531 | 6,186 | 4,957 | 5,156 |
| Other non-operating income | 711 | 56 | 402 | -143 |
| Income tax expense | 6,508 | 13,368 | -2,797 | 13,026 |
| Net income (loss) | 40,597 | 31,238 | 62,603 | 124,705 |
| Income from equity method investments | 5,531 | 6,186 | 4,957 | 5,156 |
| Amortization | 65,340 | 69,585 | 70,188 | 69,668 |
| Depreciation | 4,062 | 3,955 | 3,607 | 2,888 |
| Prepaid and deferred compensation expense | 13,700 | 5,166 | 10,195 | 12,619 |
| Non-cash equity-based compensation | 17,351 | 18,463 | 11,190 | 19,925 |
| Amortization of deferred debt issuance costs | 2,422 | 2,410 | 2,397 | 2,386 |
| Amortization of interest rate cap premium | 0 | 1,739 | 1,739 | 1,738 |
| Deferred income tax expense | 3,142 | 14,575 | 1,970 | 6,782 |
| Deferred income tax expense from common control reorganization | 0 | 619 | 0 | -137 |
| Loss (gain) on tax receivable agreement | - | -329 | -427 | -356 |
| Commissions and fees receivable net | 77,800 | 51,167 | -91,961 | 81,265 |
| Accrued interest liability | -21,470 | 21,851 | -22,260 | 21,572 |
| Other current and non-current assets | -18,524 | 18,265 | 17,126 | 4,484 |
| Other current and non-current liabilities | -227,748 | 168,934 | -42,273 | 181,988 |
| Total cash flows used in operating activities | -167,411 | 263,246 | 169,661 | 353,585 |
| Business combinations net of cash acquired and cash held in a fiduciary capacity | 0 | 109,560 | 71,792 | 9,492 |
| Capital expenditures | 13,265 | 17,275 | 14,132 | 19,816 |
| Equity method investment in vsic | - | 0 | -76 | 16,637 |
| Asset acquisitions | 0 | 0 | 2,350 | 0 |
| Repayments of prepaid incentives | - | 0 | - | - |
| Total cash flows used in investing activities | -13,265 | -126,835 | -88,198 | -45,945 |
| Proceeds from senior secured notes | - | 0 | 0 | - |
| Borrowings on revolving credit facility | 524,942 | 218,456 | 434,336 | 106,480 |
| Repayments on revolving credit facility | 279,375 | 271,071 | 498,069 | 342,788 |
| Debt issuance costs paid | 0 | 0 | 0 | 1,341 |
| Proceeds from term debt | - | 0 | 0 | - |
| Repayment of term debt | 4,250 | 4,250 | 4,250 | 4,250 |
| Receipt of contingently returnable consideration | 3,140 | 0 | 0 | 1,927 |
| Payment of contingent consideration | 17 | 0 | 0 | 4,102 |
| Tax distributions to non-controlling llc unitholders | 1,294 | 18,431 | 10,881 | 34,814 |
| Receipt of taxes related to net share settlement of equity awards | 1,714 | 726 | 22,383 | 11,222 |
| Taxes paid related to net share settlement of equity awards | 1,496 | 994 | 21,363 | 12,988 |
| Payment of tax receivable agreement liabilities | - | 25,169 | - | - |
| Class a common stock dividends and dividend equivalents paid | 16,795 | 15,514 | 16,315 | 15,436 |
| Distributions and declared distributions paid to non-controlling llc unitholders | 8,071 | 6,746 | 6,848 | 6,784 |
| Repurchases of class a common stock | 40,019 | - | - | - |
| Payment of accrued return on ryan re preferred units | - | - | 82 | 167 |
| Payments related to ryan re preferred units | 0 | 3,733 | - | - |
| Net change in fiduciary liabilities | 92,194 | -199,275 | 127,963 | -202,413 |
| Total cash flows provided by financing activities | 86,285 | 72,798 | -229,052 | -102,470 |
| Effect of changes in foreign exchange rates on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | -5,191 | 1,388 | 2,700 | 1,726 |
| Net change in cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | -99,582 | 210,597 | -144,889 | 206,896 |
| Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacitybeginning balance | 1,584,470 | 306,932 | 162,043 | 1,680,805 |
| Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacityending balance | 1,484,888 | 210,597 | -144,889 | 1,518,762 |
RYAN SPECIALTY HOLDINGS, INC. (RYAN)
RYAN SPECIALTY HOLDINGS, INC. (RYAN)